Stay updated on Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check29 days agoChange DetectedPage now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); no new people, prices, or availability data are introduced.SummaryDifference0.3%

- Check44 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check58 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as information related to diabetes prevention and drug safety. Notably, the revision number has been updated to v3.0.0.SummaryDifference3%

- Check72 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.